As primary survival factors in PCa, androgens generate a UPR response favoring adaptive responses not only by activating IRE1α signaling, but also by the inhibition of the PERK-eIF2α-axis: this would prevent the maladaptive aspects of UPR from the cancer cell's perspective. This evidence concerns the gene EIF2A and cancer.